Quick Answer
CLOVER HEALTH INVESTMENTS, CORP. /DE reported Operating Income Loss of -$85.53 million for the year ending 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -87.0% in Operating Income Loss from 2024 to 2025.
- This data is from CLOVER HEALTH INVESTMENTS, CORP. /DE's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: -$17.6 thousand | Q1 2020: -$26.63 million | Q2 2020: $23.17 million | Q3 2020: -$21.62 million | Q1 2021: -$119.09 million | Q2 2021: -$181.86 million | Q3 2021: -$149.25 million | Q1 2022: -$87.48 million | Q2 2022: -$102.73 million | Q3 2022: -$74.10 million | Q1 2023: -$79.70 million | Q2 2023: -$28.88 million | Q3 2023: -$33.62 million | Q1 2024: -$22.70 million | Q2 2024: $7.19 million | Q3 2024: -$8.79 million | Q1 2025: -$1.27 million | Q2 2025: -$10.56 million | Q3 2025: -$24.38 million.
- Over the full 7 years of available data (2019 to 2025), CLOVER HEALTH INVESTMENTS, CORP. /DE's Operating Income Loss has grown by 53.3%.
- Historical annual values: Fiscal year 2025: -$85.53 million | Fiscal year 2024: -$45.75 million | Fiscal year 2023: -$205.33 million | Fiscal year 2022: -$286.66 million | Fiscal year 2021: -$636.99 million | Fiscal year 2020: -$92.71 million | Fiscal year 2019: -$183.20 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: